Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Cited In for PubMed (Select 12649338)

1.

Expression and functions of galectin-7 in ovarian cancer.

Labrie M, Vladoiu MC, Grosset AA, Gaboury L, St-Pierre Y.

Oncotarget. 2014 Sep 15;5(17):7705-21.

2.

Galatrox is a C-type lectin in Bothrops atrox snake venom that selectively binds LacNAc-terminated glycans and can induce acute inflammation.

Sartim MA, Riul TB, Del Cistia-Andrade C, Stowell SR, Arthur CM, Sorgi CA, Faccioli LH, Cummings RD, Dias-Baruffi M, Sampaio SV.

Glycobiology. 2014 Nov;24(11):1010-21. doi: 10.1093/glycob/cwu061. Epub 2014 Jun 27.

PMID:
24973254
3.

The role of the tumor stroma in ovarian cancer.

Davidson B, Trope CG, Reich R.

Front Oncol. 2014 May 13;4:104. doi: 10.3389/fonc.2014.00104. eCollection 2014. Review.

4.

Exploring the elasticity and adhesion behavior of cardiac fibroblasts by atomic force microscopy indentation.

Codan B, Del Favero G, Martinelli V, Long CS, Mestroni L, Sbaizero O.

Mater Sci Eng C Mater Biol Appl. 2014 Jul 1;40:427-34. doi: 10.1016/j.msec.2014.04.003. Epub 2014 Apr 13.

PMID:
24857511
5.

Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy.

Vanderstraeten A, Luyten C, Verbist G, Tuyaerts S, Amant F.

Cancer Immunol Immunother. 2014 Jun;63(6):545-57.

6.

Altered tumor-cell glycosylation promotes metastasis.

Häuselmann I, Borsig L.

Front Oncol. 2014 Feb 13;4:28. doi: 10.3389/fonc.2014.00028. eCollection 2014. Review.

7.

Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.

Huang CS, Tang SJ, Chung LY, Yu CP, Ho JY, Cha TL, Hsieh CC, Wang HH, Sun GH, Sun KH.

J Am Soc Nephrol. 2014 Jul;25(7):1486-95. doi: 10.1681/ASN.2013070773. Epub 2014 Feb 7.

PMID:
24511119
8.

Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis.

White NM, Masui O, Newsted D, Scorilas A, Romaschin AD, Bjarnason GA, Siu KW, Yousef GM.

Br J Cancer. 2014 Mar 4;110(5):1250-9. doi: 10.1038/bjc.2013.828. Epub 2014 Feb 4.

9.

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer.

Zhang P, Zhang P, Shi B, Zhou M, Jiang H, Zhang H, Pan X, Gao H, Sun H, Li Z.

Cell Death Dis. 2014 Jan 9;5:e991. doi: 10.1038/cddis.2013.526.

10.

Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers.

Laderach DJ, Gentilini L, Jaworski FM, Compagno D.

Prostate Cancer. 2013;2013:519436. doi: 10.1155/2013/519436. Epub 2013 Sep 24. Review.

11.

Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer.

Chen J, Zhou SJ, Zhang Y, Zhang GQ, Zha TZ, Feng YZ, Zhang K.

World J Gastroenterol. 2013 Apr 7;19(13):2073-9. doi: 10.3748/wjg.v19.i13.2073.

12.

Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature.

Upreti M, Jamshidi-Parsian A, Apana S, Berridge M, Fologea DA, Koonce NA, Henry RL, Griffin RJ.

J Mol Med (Berl). 2013 Apr;91(4):497-506. doi: 10.1007/s00109-012-0965-1. Epub 2012 Oct 23.

13.

The immunomodulating roles of glycoproteins in epithelial ovarian cancer.

Patankar MS, Gubbels JA, Felder M, Connor JP.

Front Biosci (Elite Ed). 2012 Jan 1;4:631-50. Review.

14.

Tumor evasion from T cell surveillance.

Töpfer K, Kempe S, Müller N, Schmitz M, Bachmann M, Cartellieri M, Schackert G, Temme A.

J Biomed Biotechnol. 2011;2011:918471. doi: 10.1155/2011/918471. Epub 2011 Nov 15. Review.

15.

Galectin-1 is part of human trophoblast invasion machinery--a functional study in vitro.

Kolundžić N, Bojić-Trbojević Ž, Kovačević T, Stefanoska I, Kadoya T, Vićovac L.

PLoS One. 2011;6(12):e28514. doi: 10.1371/journal.pone.0028514. Epub 2011 Dec 8.

16.

Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity.

Cedeno-Laurent F, Opperman MJ, Barthel SR, Hays D, Schatton T, Zhan Q, He X, Matta KL, Supko JG, Frank MH, Murphy GF, Dimitroff CJ.

J Invest Dermatol. 2012 Feb;132(2):410-20. doi: 10.1038/jid.2011.335. Epub 2011 Dec 8.

17.

Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells.

Satelli A, Rao US.

Cancer Lett. 2011 Feb 1;301(1):38-46. doi: 10.1016/j.canlet.2010.10.027. Epub 2010 Nov 30.

18.

MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.

Juszczynski P, Rodig SJ, Ouyang J, O'Donnell E, Takeyama K, Mlynarski W, Mycko K, Szczepanski T, Gaworczyk A, Krivtsov A, Faber J, Sinha AU, Rabinovich GA, Armstrong SA, Kutok JL, Shipp MA.

Clin Cancer Res. 2010 Apr 1;16(7):2122-30. doi: 10.1158/1078-0432.CCR-09-2765. Epub 2010 Mar 23.

19.

A proteomic study of cMyc improvement of CHO culture.

Kuystermans D, Dunn MJ, Al-Rubeai M.

BMC Biotechnol. 2010 Mar 22;10:25. doi: 10.1186/1472-6750-10-25.

20.

Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness.

Spano D, Russo R, Di Maso V, Rosso N, Terracciano LM, Roncalli M, Tornillo L, Capasso M, Tiribelli C, Iolascon A.

Mol Med. 2010 Mar;16(3-4):102-15. doi: 10.2119/molmed.2009.00119. Epub 2009 Dec 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk